Synergistic liver-pancreas fat deposition: impact on cardiometabolic multimorbidity and cardiac dysfunction
Synergistic liver-pancreas fat deposition: impact on cardiometabolic multimorbidity and cardiac dysfunction
Background & Aims: metabolic dysfunction-associated steatotic liver disease (MASLD) and pancreatic steatosis (PS) are interconnected ectopic fat conditions linked to cardiometabolic dysregulation. Their combined effect on the long-term risk of cardiometabolic multimorbidity (CMM; ≥ 2 of diabetes, hypertension, coronary heart disease, and stroke) and cardiac remodelling remains unclear.
Methods: we examined cross-sectional associations between PS and the severity of MASLD histology in a biopsy-proven MASLD cohort from China. Subsequently, using the UK Biobank, we assessed the long-term risk of developing both incident CMM and cardiac structural/functional alterations (via cardiac magnetic resonance [CMR]) associated with single-organ versus dual-organ steatosis. Exploratory proteomic profiling was performed to identify potential molecular pathways.
Results: in the biopsy-proven cohort (n = 482), both continuous pancreatic proton density fat fraction and PS status were associated with severe hepatic steatosis, lobular inflammation, and fibrosis (all p < 0.05). In the UK Biobank cohort (n = 16 408; median follow-up of 5.6 years), the coexistence of MASLD and PS additively increased the risk of new-onset CMM (HR = 2.013, 95% CI: 1.219–3.322, p = 0.006). Dual-organ steatosis was also associated with marked cardiac alterations, specifically increased left ventricular mass and impaired ventricular function. Proteomics revealed upregulation of lysosomal catabolic and glycosaminoglycan-degrading pathways in dual-organ steatosis compared to single-organ steatosis. Gene Ontology highlighted heparan sulphate proteoglycan catabolism as a hallmark of dual-organ involvement.
Conclusion: PS is associated with greater severity of MASLD histology, and the concomitant involvement of both the liver and pancreas drives a higher risk of CMM and cardiac remodelling.
Lian, Li-You
a1293ae9-9f18-4c6e-bdea-d9831ca94887
Xia, Tianyi
b67c4fe9-9cf1-428e-8edc-7e68bba05a5b
Chen, Zhong-Wei
aa23fe30-344c-45cf-85c8-39295f8e33d7
Wen, Cai-Yun
650f63c3-64d7-4187-9967-95da95ca21b5
Zhou, Xiao-Dong
d36a40bb-d60d-4969-a319-60db45c19cc7
Xiao, Tie
d7fbb1ac-c12e-402d-ba7a-5ab27dac63d9
Targher, Giovanni
23ef21d8-f1cb-4a6a-baf4-b74acce04e91
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Yeo, Yee Hui
8f6198df-37e0-40a5-b44d-049c3f973ee3
Ju, Shenghong
2526c931-d6cb-4559-aac5-a27e965ebbee
Liu, Wen-Yue
1ef2663c-e732-499e-9ec8-2a014c1664bf
Zheng, Ming-Hua
9c79e9a5-730e-4bdf-85a8-9955ccfe7523
Lian, Li-You
a1293ae9-9f18-4c6e-bdea-d9831ca94887
Xia, Tianyi
b67c4fe9-9cf1-428e-8edc-7e68bba05a5b
Chen, Zhong-Wei
aa23fe30-344c-45cf-85c8-39295f8e33d7
Wen, Cai-Yun
650f63c3-64d7-4187-9967-95da95ca21b5
Zhou, Xiao-Dong
d36a40bb-d60d-4969-a319-60db45c19cc7
Xiao, Tie
d7fbb1ac-c12e-402d-ba7a-5ab27dac63d9
Targher, Giovanni
23ef21d8-f1cb-4a6a-baf4-b74acce04e91
Byrne, Christopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Yeo, Yee Hui
8f6198df-37e0-40a5-b44d-049c3f973ee3
Ju, Shenghong
2526c931-d6cb-4559-aac5-a27e965ebbee
Liu, Wen-Yue
1ef2663c-e732-499e-9ec8-2a014c1664bf
Zheng, Ming-Hua
9c79e9a5-730e-4bdf-85a8-9955ccfe7523
Lian, Li-You, Xia, Tianyi, Chen, Zhong-Wei, Wen, Cai-Yun, Zhou, Xiao-Dong, Xiao, Tie, Targher, Giovanni, Byrne, Christopher D., Yeo, Yee Hui, Ju, Shenghong, Liu, Wen-Yue and Zheng, Ming-Hua
(2026)
Synergistic liver-pancreas fat deposition: impact on cardiometabolic multimorbidity and cardiac dysfunction.
Liver International, 46 (3).
(doi:10.1111/liv.70548).
Abstract
Background & Aims: metabolic dysfunction-associated steatotic liver disease (MASLD) and pancreatic steatosis (PS) are interconnected ectopic fat conditions linked to cardiometabolic dysregulation. Their combined effect on the long-term risk of cardiometabolic multimorbidity (CMM; ≥ 2 of diabetes, hypertension, coronary heart disease, and stroke) and cardiac remodelling remains unclear.
Methods: we examined cross-sectional associations between PS and the severity of MASLD histology in a biopsy-proven MASLD cohort from China. Subsequently, using the UK Biobank, we assessed the long-term risk of developing both incident CMM and cardiac structural/functional alterations (via cardiac magnetic resonance [CMR]) associated with single-organ versus dual-organ steatosis. Exploratory proteomic profiling was performed to identify potential molecular pathways.
Results: in the biopsy-proven cohort (n = 482), both continuous pancreatic proton density fat fraction and PS status were associated with severe hepatic steatosis, lobular inflammation, and fibrosis (all p < 0.05). In the UK Biobank cohort (n = 16 408; median follow-up of 5.6 years), the coexistence of MASLD and PS additively increased the risk of new-onset CMM (HR = 2.013, 95% CI: 1.219–3.322, p = 0.006). Dual-organ steatosis was also associated with marked cardiac alterations, specifically increased left ventricular mass and impaired ventricular function. Proteomics revealed upregulation of lysosomal catabolic and glycosaminoglycan-degrading pathways in dual-organ steatosis compared to single-organ steatosis. Gene Ontology highlighted heparan sulphate proteoglycan catabolism as a hallmark of dual-organ involvement.
Conclusion: PS is associated with greater severity of MASLD histology, and the concomitant involvement of both the liver and pancreas drives a higher risk of CMM and cardiac remodelling.
Text
manuscript20260114
- Accepted Manuscript
Restricted to Repository staff only until 27 January 2027.
Request a copy
Text
Supplemental Tables20260114
- Accepted Manuscript
Restricted to Repository staff only until 27 January 2027.
Request a copy
Text
Figures
- Accepted Manuscript
Restricted to Repository staff only until 27 January 2027.
Request a copy
More information
Accepted/In Press date: 27 January 2026
e-pub ahead of print date: 14 February 2026
Identifiers
Local EPrints ID: 510052
URI: http://eprints.soton.ac.uk/id/eprint/510052
ISSN: 1478-3223
PURE UUID: 771c9d8f-e8e7-47e4-bfbd-a59868bcedde
Catalogue record
Date deposited: 16 Mar 2026 17:49
Last modified: 21 Mar 2026 02:41
Export record
Altmetrics
Contributors
Author:
Li-You Lian
Author:
Tianyi Xia
Author:
Zhong-Wei Chen
Author:
Cai-Yun Wen
Author:
Xiao-Dong Zhou
Author:
Tie Xiao
Author:
Giovanni Targher
Author:
Yee Hui Yeo
Author:
Shenghong Ju
Author:
Wen-Yue Liu
Author:
Ming-Hua Zheng
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics